复星医药
(600196)
| 流通市值：524.11亿 | | | 总市值：660.66亿 |
| 流通股本：21.18亿 | | | 总股本：26.70亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 13,715,962,783.55 | 13,523,933,130.64 | 13,507,968,050.27 | 14,080,458,961.33 |
| 应收票据及应收账款 | 7,889,295,018.97 | 8,024,433,379.34 | 8,455,763,829.25 | 8,246,247,365.28 |
| 其中：应收票据 | 31,945,231.82 | 72,360,821.52 | 39,863,241.76 | 83,672,043.9 |
| 应收账款 | 7,857,349,787.15 | 7,952,072,557.82 | 8,415,900,587.49 | 8,162,575,321.38 |
| 应收款项融资 | 598,017,849.67 | 612,972,773.36 | 581,006,972.93 | 471,388,670.03 |
| 预付款项 | 1,117,987,019.49 | 864,975,288.07 | 967,836,158.08 | 875,866,512.06 |
| 其他应收款合计 | 731,448,048.83 | 665,062,759.27 | 701,701,033.55 | 667,147,954.49 |
| 应收股利 | 8,852,336.96 | 8,852,336.96 | 8,852,336.97 | - |
| 存货 | 6,823,049,926.17 | 7,258,648,636.81 | 7,435,227,104.84 | 7,511,698,994.5 |
| 合同资产 | 131,501,387.82 | 127,553,495.72 | 81,715,178.48 | 129,765,752.28 |
| 其他流动资产 | 723,224,241.82 | 742,516,123.81 | 602,024,017.39 | 722,812,258.72 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 34,438,609,708.93 | 34,491,060,582.73 | 34,527,299,352.05 | 34,797,913,650.75 |
| 非流动资产: | | | | |
| 长期应收款 | 191,094,757.88 | 199,435,549.76 | 89,088,743.05 | 85,574,138.62 |
| 长期股权投资 | 25,018,325,383.83 | 24,691,500,903.85 | 24,945,672,701.77 | 25,104,724,418.6 |
| 其他权益工具投资 | 17,291,880.8 | 16,433,872.48 | 13,693,570.56 | 13,514,013.21 |
| 其他非流动金融资产 | 1,199,916,094.54 | 1,157,129,201.97 | 929,663,864.01 | 1,029,426,152.21 |
| 固定资产 | 17,447,702,895.9 | 17,385,194,733.55 | 14,923,836,331.96 | 14,607,339,806.3 |
| 在建工程 | 3,555,113,496.42 | 3,435,450,886.76 | 4,666,715,968.67 | 4,888,480,741.46 |
| 使用权资产 | 2,653,976,037.24 | 2,589,903,279.92 | 2,270,781,259.43 | 2,062,257,039.33 |
| 无形资产 | 14,371,961,152.18 | 14,468,392,991.02 | 13,031,835,137.26 | 13,278,386,063.18 |
| 开发支出 | 5,032,730,916.13 | 4,867,845,013.24 | 4,895,929,231.72 | 4,506,343,106.41 |
| 商誉 | 10,888,057,665.05 | 10,905,083,403.95 | 10,800,669,199 | 10,880,283,288.16 |
| 长期待摊费用 | 1,342,330,355.22 | 1,382,281,478.53 | 1,053,960,382.25 | 951,026,523.11 |
| 递延所得税资产 | 754,081,171.39 | 757,775,922.87 | 791,144,883.76 | 660,090,437.27 |
| 其他非流动资产 | 1,079,297,374.58 | 1,113,079,528.64 | 2,324,471,131.65 | 2,672,454,787.28 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 83,551,879,181.16 | 82,969,506,766.54 | 80,737,462,405.09 | 80,739,900,515.14 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 117,990,488,890.09 | 117,460,567,349.27 | 115,264,761,757.14 | 115,537,814,165.89 |
| 流动负债: | | | | |
| 短期借款 | 17,874,459,151.28 | 18,711,314,899.45 | 18,679,639,582.44 | 17,317,213,155.88 |
| 交易性金融负债 | 14,356,400 | - | - | - |
| 应付票据及应付账款 | 5,438,826,198.49 | 5,997,385,085.53 | 6,342,057,150.34 | 6,525,945,343.19 |
| 其中：应付票据 | 568,967,440.67 | 619,015,240.91 | 816,474,047.07 | 719,152,245.39 |
| 应付账款 | 4,869,858,757.82 | 5,378,369,844.62 | 5,525,583,103.27 | 5,806,793,097.8 |
| 合同负债 | 1,426,224,944.81 | 1,232,314,688.93 | 1,007,116,288.38 | 1,082,436,920.75 |
| 应付职工薪酬 | 1,543,012,041.86 | 1,978,490,214.56 | 1,682,723,247.65 | 1,458,207,171.09 |
| 应交税费 | 649,016,583.47 | 560,734,826.38 | 537,016,754.88 | 520,971,887.24 |
| 其他应付款合计 | 4,107,777,411.47 | 4,348,817,521.46 | 4,140,748,898.28 | 4,660,845,600.3 |
| 应付股利 | 10,590,840.27 | 13,328,198.32 | 46,955,296.32 | - |
| 一年内到期的非流动负债 | 4,184,384,414.37 | 4,461,323,175.98 | 5,005,300,788.55 | 5,716,663,298.63 |
| 其他流动负债 | 136,607,871.78 | 162,288,840.5 | 122,979,383.85 | 119,578,394.36 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 35,500,536,915.25 | 37,452,669,252.79 | 37,517,582,094.37 | 37,401,861,771.44 |
| 非流动负债: | | | | |
| 长期借款 | 11,560,443,014.28 | 10,203,500,106.86 | 8,630,183,539.06 | 9,559,300,502.32 |
| 应付债券 | - | 240,000,000 | 240,000,000 | 240,000,000 |
| 租赁负债 | 2,629,469,289.52 | 2,541,967,607.34 | 2,217,236,916.94 | 1,957,876,207.33 |
| 长期应付款 | 644,314,233.05 | 572,090,710.24 | 615,863,880.74 | 564,717,573.8 |
| 长期应付职工薪酬 | 117,207,029.53 | 189,446,448.64 | 174,091,466.87 | 165,207,056.25 |
| 递延收益 | 649,905,225.02 | 657,891,060.8 | 605,077,498.44 | 613,685,923.67 |
| 递延所得税负债 | 3,444,772,345.7 | 3,245,158,851.91 | 3,464,986,579.56 | 3,406,679,758.58 |
| 其他非流动负债 | 2,593,938,909.66 | 2,424,114,398.37 | 2,605,135,611.53 | 2,766,543,747.44 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 21,640,050,046.76 | 20,074,169,184.16 | 18,552,575,493.14 | 19,274,010,769.39 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 57,140,586,962.01 | 57,526,838,436.95 | 56,070,157,587.51 | 56,675,872,540.83 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,671,326,465 | 2,671,326,465 | 2,671,326,465 | 2,672,398,711 |
| 资本公积 | 16,663,191,198.8 | 16,591,495,024.23 | 17,524,643,878.68 | 17,568,232,300.17 |
| 减:库存股 | 295,562,216.64 | 234,375,403.49 | 206,895,300.74 | 74,255,616.52 |
| 其他综合收益 | -1,425,281,108.99 | -1,312,538,706.73 | -1,473,923,714.2 | -1,199,677,483.78 |
| 盈余公积 | 2,992,140,842.96 | 2,992,140,842.96 | 2,958,415,025.58 | 2,958,415,025.58 |
| 未分配利润 | 27,317,816,388.82 | 26,553,058,638.76 | 25,827,906,740.92 | 25,042,087,067.69 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 47,923,631,569.95 | 47,261,106,860.73 | 47,301,473,095.24 | 46,967,200,004.14 |
| 少数股东权益 | 12,926,270,358.13 | 12,672,622,051.59 | 11,893,131,074.39 | 11,894,741,620.92 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 60,849,901,928.08 | 59,933,728,912.32 | 59,194,604,169.63 | 58,861,941,625.06 |
| 负债和股东权益合计 | 117,990,488,890.09 | 117,460,567,349.27 | 115,264,761,757.14 | 115,537,814,165.89 |
| 公告日期 | 2025-04-30 | 2025-03-26 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |